First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma

J Nucl Med. 2023 Feb;64(2):337-338. doi: 10.2967/jnumed.122.264626. Epub 2022 Sep 15.

Nils Florian Trautwein^{1

2}, Gerald Reischl^{2

3}, Christian Seitz⁴, Helmut Dittmann¹, Ferdinand Seith⁴, Sophia Scheuermann⁵, Tobias Feuchtinger⁶, Frank Dombrowski⁷, Rupert Handgretinger⁵, Jörg Fuchs⁸, Bernd Pichler^{2

3

9}, Christian la Fougère^{10

3

9}, Johannes Schwenck^{1

2

3}

¹ Department of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen, Tübingen, Germany.
² Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany.
³ Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany.
⁴ Department of Radiology, University of Tübingen, Tübingen, Germany.
⁵ Department of Pediatric Hematology and Oncology, University of Tübingen, Tübingen, Germany.
⁶ Department of Pediatric Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, University of Munich, Munich, Germany.
⁷ Department of Pathology, University of Greifswald, Greifswald, Germany.
⁸ Department of Pediatric Surgery, University of Tübingen, Tübingen, Germany; and.
⁹ German Cancer Consortium, Partner Site Tübingen, Tübingen, Germany.
¹⁰ Department of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen, Tübingen, Germany; christian.lafougere@med.uni-tuebingen.de.

No abstract available

Publication types